Q2 2021 Holdings
Filed 2021-08-16 | 29 holdings | $104.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-10-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $29.3M | 1,668,987 | 28.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $20.9M | 870,967 | 20.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $18.2M | 481,094 | 17.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.9M | 704,317 | 13.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.1M | 1,367,582 | 10.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $10.8M | 323,437 | 10.4% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $21.8K | 3,096,729 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $15.4K | 3,529,465 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $14.9K | 440,869 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $13.0K | 621,493 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $11.0K | 1,748,241 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $10.6K | 393,850 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $10.5K | 3,331,315 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $9.5K | 210,600 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $8.1K | 281,911 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $7.2K | 298,839 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $6.9K | 2,929,447 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $6.5K | 2,059,729 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.4K | 305,125 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.1K | 326,336 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.8K | 429,228 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.4K | 226,671 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $4.3K | 125,000 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.6K | 262,658 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $3.5K | 145,453 | 0.0% |
| Catabasis Pharmaceuticals in(CATBEUR) | COM NEW | 14875P206 | $3.4K | 1,617,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN)A | COM | 92790C104 | $3.4K | 186,405 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $3.0K | 97,143 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $2.6K | 250,000 | 0.0% |